Royal Philips's sales declined 6% year-over-year in the second quarter of 2020 to €4.4bn ($4.9bn), but the company's revenue was partly buoyed by demand for respiratory devices.
The COVID-19 pandemic caused a steep decrease in demand for procedures and postponement of equipment installations in hospitals, resulting in lower revenues for Philips in the second quarter compared to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?